CureZone   Log On   Join
Re: research study on OP
 
larryb Views: 6,005
Published: 18 y
 
This is a reply to # 1,027,603

Re: research study on OP


Of course this is something you know intuitively the first few times you pull. But we need our studies to be convinced. Although I'm not sure why anymore. Studies and clinical trials are compromised to steer profitable "outcomes", non-compromised studies are spun to the public to have their conclusions misprepresented etc.

A classic case of the latter is the recent headline that the media has repeated at nauseum that cancer survival rates have had major increases in the last two years. And the huge media exposure only reinforces the perception that there's been an astounding breakthrough in mainstream cancer care that the world needs to know about RIGHT NOW! Read the fine print and you see that this is about only a 2% increase in survival (defined as living for 5 years with the stuff) in the last two years. Significant? Even putting aside differences in early detection, different ways of sampling or definitions of survival, etc, it doesn't even crack the margin of error for sampling or reporting. In other words, by all practical and statistical standards there's been no significant improvement if any despite all the manufactured public opinion.

If studies of OP showed long term a decrease of 2% in oral health related issues, believe me it wouldn't make fox news or CNN (unless as proof that another atlernative therapy was an ineffective hoax). Sorry, just had to vent - I do that alot these days.
 

Share


 
Printer-friendly version of this page Email this message to a friend
Alert Moderators
Report Spam or bad message  Alert Moderators on This GOOD Message

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


 

Donate to CureZone


CureZone Newsletter is distributed in partnership with https://www.netatlantic.com


Contact Us - Advertise - Stats

Copyright 1999 - 2025  www.curezone.org

0.108 sec, (1)